Drawing for LB

USPTO serial 79254778

LB

Reviewed by CopyMark Law Group

Reg. 5887781Status 709
Filing date
Status date
Registration date
Oct 22, 2019
Examiner
HUSSAIN, TASNEEM
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for treating multiple myeloma, blood cancer and solid tumor; chemico-pharmaceutical preparations for treating multiple myeloma, blood cancer and solid tumor; drugs for medical purposes for treating multiple myeloma, blood cancer and solid tumor; serotherapeutic medicines; biological preparations for medical purposes for treating multiple myeloma, blood cancer and solid tumor; chemical preparations for pharmaceutical purposes for treating multiple myeloma, blood cancer and solid tumor; stem cells for medical purposes; biological tissue cultures for medical purposes; biochemical drug for treating multiple myeloma, blood cancer and solid tumor; blood products, namely, blood plasmaSECTION 71 - CANCELLED—
042Technical research in the field of pharmaceutical studies; consulting services for others in the field of design, planning, and implementation project management of scientific research; research and development of new products for others; scientific laboratory services; chemical analysis; chemistry consultation; chemical research; bacteriological research; biological researchSECTION 71 - CANCELLED—
044Medical clinic services; medical assistance; telemedicine services; medical, physical rehabilitation and physical therapy services; preparation of prescriptions by pharmacists; hospital services; health care; medical and pharmaceutical consultation; nursing, medical; veterinary servicesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 8, 2026C71TCANCELLED SECTION 71—
Oct 22, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 20, 2024CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jan 15, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jan 15, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 15, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 15, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 15, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 15, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 7, 2020FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 14, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 14, 2020FIMPFINAL DISPOSITION PROCESSED—
Jan 22, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 22, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 6, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 6, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 17, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 1, 2019ALIEASSIGNED TO LIE—
Jun 20, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 12, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 11, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 11, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 18, 2019RFNTREFUSAL PROCESSED BY IB—
Apr 30, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 30, 2019RFRRREFUSAL PROCESSED BY MPU—
Apr 6, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 5, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 4, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 2, 2019DOCKASSIGNED TO EXAMINER—
Apr 2, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 27, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Mar 21, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance